Summaries like this, in your inbox every morning.
Sign up free →GAZE (Grounded Agentic Zero-shot Evaluation) lets medical vision-language models call viewer-level tools (zoom, windowing, contrast, edge detection) and retrieval tools backed by PubMed and Open-i, with structured outputs validated against a schema and full tool-call traces recorded for auditability.
On NOVA, a benchmark of 906 brain MRI cases covering 281 rare neurological conditions, GAZE reaches 58.2 mean average precision (mAP) at intersection-over-union (IoU) 0.3 for lesion localization and 34.9% Top-1 diagnostic accuracy under a joint protocol scoring captioning, diagnosis, and localization, without task-specific fine-tuning.
Tool use helps rare pathologies disproportionately: the fraction of cases with IoU > 0.3 rises from 17% to 58% for diagnoses with three or fewer examples versus 25% to 68% for common conditions (≥10 cases), with retrieval ablations revealing a model-dependent trade-off in which gains in diagnosis can coincide with losses in localization.
No comments yet. Be the first to share your thoughts!
Log in to join the discussion




Get curated AI news from 200+ sources delivered daily to your inbox. Free to use.
Get Started FreeFree · takes 30 seconds · unsubscribe anytime
1 minute a day. The AI essentials.
200+ sources · Email / LINE / Slack